Abstract
Melatonin, a neurohormone regulating circadian rhythms, also plays a role in hair follicle physiology through its antioxidant and anti-inflammatory effects. This scoping review aimed to assess preclinical and clinical evidence supporting melatonin as a therapeutic option for alopecia. A systematic search of MEDLINE, Scopus, and DOAJ identified studies on androgenetic alopecia, telogen effluvium, and diffuse hair loss. Preclinical findings suggest melatonin promotes follicular stem cell proliferation, modulates signaling pathways, and protects against damage. Clinical trials indicate that topical melatonin increases hair density, prolongs the anagen phase, and reduces hair shedding with minimal adverse effects. While current evidence supports its potential, variability in study design highlights the need for standardized clinical trials.
License
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Article Type: Review Article
ELECTRON J GEN MED, Volume 22, Issue 4, August 2025, Article No: em669
https://doi.org/10.29333/ejgm/16520
Publication date: 01 Jul 2025
Online publication date: 18 Jun 2025
Article Views: 137
Article Downloads: 159
Open Access References How to cite this article